Resmed CEO Mick Farrell (NYSE: RMD) reported … [Read more...]
Resmed Allays Tariff Concerns, Reports Strong Revenue Growth in Q3 Earnings Call
5 Takeaways from AASM’s New Position Statement on Daytime Sleepiness
Chronic sleepiness is more damaging than we think, the American Academy of Sleep Medicine said.
The American Academy of Sleep Medicine’s (AASM) … [Read more...]
Resmed Launches NightOwl Home Sleep Apnea Test
The noninvasive, fingertip device collects up to 10 nights’ worth of sleep data.
Resmed has introduced a noninvasive sleep apnea … [Read more...]
VieMed CEO: ‘Blue Ocean of Opportunity’ to Serve More Patients, Grow Business
In its year-end 2024 earnings call, the HME provider discussed strong ventilator, sleep sales.
VieMed CEO Casey Hoyt has described an enormous … [Read more...]
Briefly: NHIA Welcomes 2025 Class of Fellows; World Sleep Day Focuses on Sleep Health Education
Featuring the National Home Infusion Association, ResMed, and World Sleep Day.
NHIA Announces 2025 Fellows The National Home … [Read more...]
Fisher & Paykel to Construct Fifth Building in New Zealand
The new facility is expected to open in 2027.
Fisher & Paykel Healthcare Corp. (NZX: FPH) is … [Read more...]
CAIRE Adds Accurate Biomed Services to Authorized Service Network
Accurate Biomed is one of the nation’s largest independent service providers for respiratory and biomedical equipment.
Respiratory patients needing service for their … [Read more...]
Patient-Direct Segment Takes Center Stage as Owens & Minor Considers Divesting Enterprise-Focused Business Line
The company is considering a sale of its products and health-care services segment, which mainly serves institutional providers.
Owens & Minor (NYSE: OMI) is putting all its … [Read more...]
AdaptHealth Posts $3.26B in 2024 Revenue; CEO Highlights AI, Diabetes Turnaround, Capitated Contracts
Growth in respiratory, sleep segments offset declines in diabetes health, the company reported.
AdaptHealth (Nasdaq: AHCO) closed out 2024 on a … [Read more...]
Q2 Earnings Call: ResMed Focuses on ‘Three Key Pillars’ Strategy
ResMed has “a lot of runway ahead” in its core sleep apnea treatment market.
ResMed’s second-quarter 2025 earnings call on Jan. … [Read more...]